Brief: Neurovive Pharmaceutical Q3 Pre-Tax Loss Widens To SEK 15 Million
Nov 22 (Reuters) - NeuroVive Pharmaceutical AB NVP.ST :
* Q3 PRE-TAX RESULTS AT 14 982 (-13 179) KSEK
Source text for Eikon: ID:nWkr8kh6J3
Further company coverage: NVP.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))